To investigate the clinical effect and mechanism of Jianpi Bushen Huatan Fang in the treatment of stable chronic obstructive pulmonary disease (COPD) patients.
A total of 70 patients with stable COPD in our hospital were enrolled and 5 patients withdrew from the study. All the patients maintained the original regular medication program, they were divided into the Chinese medicine group (n=32, taken oral Jianpi Bushen Huatan Fang twice a day), and the control group (n=33, taken placebo twice a day). The treatment course was 2 months, and the follow-up was for 4 months. The traditional Chinese medicine (TCM) syndrome score was used to determine the TCM curative effect. The lung function was evaluated by the severity of the airflow limitation, and the COPD assessment test (CAT) was used for comprehensive evaluation. The peripheral blood immunocytic markers (CD4+ and CD8+ T lymphocyte), inflammatory cytokines and Th1/Th2 cytokine (TNF-α, IL-8, CXCL10, INF-γ and IL-4) were detected as well.
After 2 and 4 months follow-up, the total effective rate of Chinese medicine group was higher than that of the control group (P<0.05). After 4 months of follow-up, the mild patients with lung function grade and CAT score in Chinese medicine group were increased than those of control group, and the severe or the extremely severe patients with lung function grade and extremely severe patients with the CAT score in Chinese medicine group were reduced than those of control group (P<0.05). After 2 and 4 months of follow up, in Chinese medicine group the INF-γ, CXCL10 were decreased and the IL-4 was increased (P<0.05) compared with before treatment, and the INF-γ and CXCL10 were lower (P<0.05) compared with those in control group. After 2 and 4 months of follow-up, there was no significant difference in the TNF-α, IL-8, CD4+ and CD8+ T lymphocyte between the two groups (P>0.05).
Jianpi Bushen Huatan Fang can alleviate COPD disease progression and improve the life quality of stable COPD patients by regulating Th1/Th2 cytokine and improving CD4+ and CD8+ T lymphocytes.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |